Clinical trial
Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors
NCT02303015 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2014
- Completion date
- June 30, 2023
- Enrollment
- 430 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
germ cell cancer